Identification of Mutations Conferring Tryptanthrin Resistance to <i>Mycobacterium smegmatis</i>
Tuberculosis (TB), caused by <i>Mycobacterium tuberculosis</i>, is a global burden, responsible for over 1 million deaths annually. The emergence and spread of drug-resistant <i>M. tuberculosis</i> strains (MDR-, XDR- and TDR-TB) is the main challenge in global TB-control, re...
Saved in:
Main Authors: | , , , , , , , |
---|---|
Format: | Book |
Published: |
MDPI AG,
2020-12-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
MARC
LEADER | 00000 am a22000003u 4500 | ||
---|---|---|---|
001 | doaj_eba55414ef7d4fe08d6edc68f9a37f3e | ||
042 | |a dc | ||
100 | 1 | 0 | |a Svetlana G. Frolova |e author |
700 | 1 | 0 | |a Ksenia M. Klimina |e author |
700 | 1 | 0 | |a Ravinder Kumar |e author |
700 | 1 | 0 | |a Aleksey A. Vatlin |e author |
700 | 1 | 0 | |a Deepak B. Salunke |e author |
700 | 1 | 0 | |a Pravin Kendrekar |e author |
700 | 1 | 0 | |a Valery N. Danilenko |e author |
700 | 1 | 0 | |a Dmitry A. Maslov |e author |
245 | 0 | 0 | |a Identification of Mutations Conferring Tryptanthrin Resistance to <i>Mycobacterium smegmatis</i> |
260 | |b MDPI AG, |c 2020-12-01T00:00:00Z. | ||
500 | |a 10.3390/antibiotics10010006 | ||
500 | |a 2079-6382 | ||
520 | |a Tuberculosis (TB), caused by <i>Mycobacterium tuberculosis</i>, is a global burden, responsible for over 1 million deaths annually. The emergence and spread of drug-resistant <i>M. tuberculosis</i> strains (MDR-, XDR- and TDR-TB) is the main challenge in global TB-control, requiring the development of novel drugs acting on new biotargets, thus able to overcome the drug-resistance. Tryptanthrin is a natural alkaloid, with great therapeutic potential due to its simple way of synthesis and wide spectrum of biological activities including high bactericidal activity on both drug-susceptible and MDR <i>M. tuberculosis</i> strains. InhA was suggested as the target of tryptanthrins by in silico modeling, making it a promising alternative to isoniazid, able to overcome drug resistance provided by <i>katG</i> mutations. However, neither the mechanism of action of tryptanthrin nor the mechanism of resistance to tryptanthrins was ever confirmed in vitro. We show that the MmpS5-MmpL5 efflux system is able to provide resistance to tryptanthrins using an in-house test-system. Comparative genomic analysis of spontaneous tryptanthrin-resistant <i>M. smegmatis</i> mutants showed that mutations in <i>MSMEG_1963</i> (EmbR transcriptional regulator) lead to a high-level resistance, while those in <i>MSMEG_5597</i> (TetR transcriptional regulator) to a low-level one. Mutations in an MFS transporter gene (<i>MSMEG_4427</i>) were also observed, which might be involved in providing a basal level of tryptanthrins-resistance. | ||
546 | |a EN | ||
690 | |a tuberculosis | ||
690 | |a mycobacterium smegmatis | ||
690 | |a tryptanthrin | ||
690 | |a drug resistance | ||
690 | |a efflux | ||
690 | |a Therapeutics. Pharmacology | ||
690 | |a RM1-950 | ||
655 | 7 | |a article |2 local | |
786 | 0 | |n Antibiotics, Vol 10, Iss 1, p 6 (2020) | |
787 | 0 | |n https://www.mdpi.com/2079-6382/10/1/6 | |
787 | 0 | |n https://doaj.org/toc/2079-6382 | |
856 | 4 | 1 | |u https://doaj.org/article/eba55414ef7d4fe08d6edc68f9a37f3e |z Connect to this object online. |